Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries - Prevalence, real-world testing pathways, and treatment implications
Favorite
Share
More Options
12

Open in WPS to view all 12 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
